AIV
39
6
ROK
46
3
MS
64
3
XEL
48
11
OI
23
3
WU
26
2
SLB
41
2
HPQ
55
3
ORCL
49
3
PWR
63
3
FOX
71
3
HST
53
4
AEP
45
5
GD
42
4
MAS
46
3
O
26
16
FCX
44
4
HP
44
14
CHD
34
7
CTAS
36
8
AIV
39
6
ROK
46
3
MS
64
3
XEL
48
11
OI
23
3
WU
26
2
SLB
41
2
HPQ
55
3
ORCL
49
3
PWR
63
3
FOX
71
3
HST
53
4
AEP
45
5
GD
42
4
MAS
46
3
O
26
16
FCX
44
4
HP
44
14
CHD
34
7
CTAS
36
8
Financhill
Back

Pliant Therapeutics 10K Form

Sell
29

PLRX
Pliant Therapeutics

Last Price:
$13.22
Seasonality Move:
6.8%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive PLRX News And Ratings

See the #1 stock for the next 7 days that we like better than PLRX

PLRX Financial Statistics

Sales & Book Value

Annual Sales: $1.6M
Cash Flow: $-33.2M
Price / Cash Flow: 0
Annual Sales: $5.68
Price / Book: 2.33

Profitability

EPS (TTM): -3.34000
Net Income (TTM): $-201.7M
Gross Margin: --
Return on Equity: 0%
Return on Assets: 0%

Pliant Therapeutics Earnings Forecast

Key Pliant Therapeutics Financial Ratios

  • The Research & Development expenses have been 8,088.42% of Revenue.
  • The Interest Expense is -0.79% of Operating Income.
  • The Net Earning history of PLRX is -10,211.14% of Total Revenues.
  • Per Share Earnings over the last 6 years have been positive in 2 years.

Pliant Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: PLRX
CUSIP: 729139
Website: pliantrx.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

PLRX Technical Analysis vs Fundamental Analysis

Sell
29
Pliant Therapeutics (PLRX) is a Sell

Is Pliant Therapeutics a Buy or a Sell?